Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type

Diagnostic Cytopathology

Volumn 20, Issue 2, 1999, Pages 57-62

  Kho Duffin, Jennie ^a   Tao, Liang Che ^a   Cramer, Harvey ^a   Catellier, Michele J ^b   Irons, Daniel ^c   Ng, Peter ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Winona Memorial Hospital   (United States)

^c Austin Diagnostic Clinic Hepatitis Center   (United States)

^d MCLAREN REGIONAL MEDICAL CENTER   (United States)

Author keywords

Cytopathology; Mesothelial cells; Mesothelioma; Serous effusion

Indexed keywords

HYALURONIC ACID;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CELL TYPE; CLINICAL ARTICLE; CYTODIAGNOSIS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; BIOPSY; CELL ADHESION; CELL SIZE; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT;

EID: 0032929654     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199902)20:2<57::AID-DC2>3.0.CO;2-M     Document Type: Article

References (32)

1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North West Cape Province. Br J Ind Med 1960;17:260-271.
2. Pedio G, Landolt-Weber U. Cytologic presentation of malignant mesothelioma in pleural effusions. Exp Cell Biol 1988;36:211-216.
3. Taryle DA, Lakshminarayan S, Sahn A. Pleural mesotheliomas - an analysis of 18 cases and review of the literature. Medicine (Baltimore) 1976;55:153-162.
4. Whitaker D, Shikin KB. Diagnosis of pleural malignant mesothelioma in life - a practical approach. J Pathol 1984;143:147-175.
5. Tuo LC. The cytopathology of mesothelioma. Acta Cytol 1979;23:209-213.
6. Sterrett GK, Whitaker D, Shilkin KB, Walters M. Fine needle aspiration cytology of malignant mesothelioma. Acta Cytol 1987;31:185-193.
7. Triol JH, Conston AS, Chandler SV. Malignant mesothelioma. Cytopathology of 75 cases seen in a New Jersey community hospital. Acta Cytol 1984;28:37-45.
8. Tao LC. Cytopathology of malignant effusions. Chicago: ASCP Press; 1996. p 203-229.
9. Sherman M, Mark E. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990;114:845-851.
10. Tao LC. Aspiration biopsy cytology of mesothelioma. Diagn Cytopathol 1989;5:14-21.
11. Roberts HG, Campbell GM. Exfoliative cytology of diffuse mesothelioma. J Clin Pathol 1972;25:577-582.
12. Whitaker D. Cell aggregates in malignant mesothelioma. Acta Cytol 1977;21:236-239.
13. Whitker D, Shilkin KB. The cytology of malignant mesothelioma in Western Australia. Acta Cytol 1978;22:67-70.
14. Klima M, Spjul HF, Seybold WD. Diffuse malignant mesothelioma. Am J Clin Pathol 1976;65:583-600.
15. Tao LC. Cytopathology of malignant effusions. Chicago: ASCP Press; 1996. p 17-55.
16. Stevens M, Leong A, Fazzalari N, Dowling KD. Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 1992;8:333-341.
17. Klempman S. The exfoliative cytology of diffuse pleural mesothelioma. Cancer 1962;15:691-704.
18. Herbert A. Editorial. The diagnosis of malignant mesothelioma. J Pathol 1984;143:145-146.
19. Boon M, Veldhuizen RW, Ruinaard C, Snieders MW, Kwee WS. Qualitative distinctive differences between the vacuoles of mesothelioma cells and of cells from metastatic carcinoma exfoliated in pleural fluid. Acta Cytol 1984;28:443-449.
20. Berge T, Grontoft O. Cytologic diagnosis of malignant pleural mesothelioma. Acta Cytol 1965;9:207-212.
21. Koss LG. Diagnostic cytology and its histopathologic bases. 2nd ed. Philadelphia: Lippincott; 1968. p 505.
22. Luse SA, Reagan J. A histocytological study of effusions. Effusions not associated with malignant tumors. Cancer 1958;7:1155-1166.
23. Kobzik L, Antman KH, Warhol MJ. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy. Acta Cytol 1985;29:219-225.
24. Warhol MJ, Corson JM. An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast. Hum Pathol 1985;16:50-55.
25. Battifora H. The pleura. In: Sternberg S, editor. Diagnostic surgical pathology, Volume 1. New York: Raven Press; 1994. p 1095-1123.
26. Kwee WS, Veldhuizen RW, Golding RP. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Virchows Arch [A] 1982;397:287-299.
27. Benjamin CJ, Ritchie A. Histological staining for the diagnosis of mesothelioma. Am J Med Technol 1982;48:905-908.
28. Battifora H, Kopinski M. Distinction of mesothelioma from adenocarcinoma; an immunohistochemical approach. Cancer 1985;55:1679-1685.
29. Duggan MA, Masters C, Alexander F. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for CEA antigen, keratin and vimentin. Acta Cytol 1987;31:807-814.
30. Wang N, Huang SN, Gold P. Absence of CEA antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer 1979;44:937-943.
31. Shebani K, Battifora H. Antigenic phenotype of malignant mesothelioma and pulmonary adenocarcinoma: an immunohistochemical analysis demonstrating the value of LeuM1 antigen. Am J Pathol 1986;123: 212-219.
32. Szpak CA, Johnston WW, Lottich SC, et al. Patterns of reactivity of 4 novel monoclonal antibodies (B72.3, DF3, B1.1, and B6.2) with cells in human malignant and benign effusions. Acta Cytol 1984;28:356-367.